[Jongkees-group.beta] Invitation KNCV OC autumn symposium

[Ruijter, E. (Eelco)]

English below


Beste collega's,


Vrijdag 22 november zal het jaarlijkse KNCV organische chemie najaarssymposium plaatsvinden in Leiden, aan de hogeschool Leiden. Het symposium, voornamelijk gericht op studenten, staat in het teken van 'Drug Discovery and Development' met daarin 8 lezingen van academische onderzoekers en professionals uit de industrie. In de 8 lezingen zullen zij je spannend onderzoek, ontdekkingen en technologieën laten zien die ons helpen nieuwe therapieën te ontwikkelen.


Het symposium is gratis toegankelijk, maar je moet je wel aanmelden via de onderstaande website:

https://soc.kncv.nl/autumn-24


Het exacte programma, met de titels van de lezingen, volgt nog (op onze website), maar de onderstaande spreker hebben bevestigd:


Paul P. Geurink (Leiden University Medical Center) - Chemical Biology and Drug Discovery

Mark de Lange (ProQR Therapeutics) - RNA-based Therapies

Nathaniel Martin (Leiden University) - Infectious Disease Drug Discovery

Elmer Maurits (iProtics) - Hematological Cancer and Auto-Immunity Treatment

Peter Timmerman (BioSynth) - Peptide Engineering Technology

Danielle Vugts (Amsterdam University Medical Center) - Radiology and Nuclear Medicine

Gerard van Westen (Leiden University) - Computational Drug Discovery

*** Spreker uit de industrie volgt nog ***


Wij hopen jullie vrijdag 22 november te mogen verwelkomen in Leiden op ons symposium.


Met vriendelijke Groet,

KNCV-SOC bestuur, Alphert Christina & Teunie van Herk (Hogeschool Leiden)


---------------------------------------------------------------------------------------------------------------------------------------------------------


Dear colleagues,


Friday the 22nd of November the annual KNCV organic chemistry Autumn Symposium will take place in Leiden, at the University of Applied Sciences in Leiden. The topic of the symposium, primarily oriented at BSc and MSc students, will be 'Drug Discovery and Development' with 8 exciting lectures from academic researchers and industry professionals. In these 8 lectures they will show you exiting research, discoveries and technologies to develop new therapies.


The symposium will be free of charge, but you do need to register on the website below:

https://soc.kncv.nl/autumn-24


The exact program, with lecture titles, will be announced soon on our website, but the following speakers confirmed:


Paul P. Geurink (Leiden University Medical Center) - Chemical Biology and Drug Discovery

Mark de Lange (ProQR Therapeutics) - RNA-based Therapies

Nathaniel Martin (Leiden University) - Infectious Disease Drug Discovery

Elmer Maurits (iProtics) - Hematological Cancer and Auto-Immunity Treatment

Peter Timmerman (BioSynth) - Peptide Engineering Technology

Danielle Vugts (Amsterdam University Medical Center) - Radiology and Nuclear Medicine

Gerard van Westen (Leiden University) - Computational Drug Discovery

*** Industrial speaker to be announced ***


We hope to welcome you Friday the 22nd of November in Leiden at our symposium.


Sincerely yours

KNCV-SOC board, Alphert Christina & Teunie van Herk (University of Applied Sciences Leiden)



Prof. Dr. Eelco Ruijter │  Chair of Synthetic Organic Chemistry & Catalysis │  Vrije Universiteit Amsterdam

Department of Chemistry & Pharmaceutical Sciences │ Amsterdam Institute for Molecular & Life Sciences (AIMMS)

Email<mailto:e.ruijter at vu.nl>  │  Website <https://www.socc.nl/>  │  ORCID<https://orcid.org/my-orcid?orcid=0000-0002-1105-3947>  │  VU Research Portal<https://research.vu.nl/en/persons/e-ruijter>  │  X<https://twitter.com/RuijterLab>  │  LinkedIn<https://www.linkedin.com/in/eelco-ruijter-05523514/> │  Visiting address<https://www.google.com/maps/place/O2+gebouw,+De+Boelelaan+1108,+1081+HZ+Amsterdam/@52.3356682,4.8582295,17z/data=!3m1!4b1!4m6!3m5!1s0x47c5e1e2c9a2c86b:0xce9c0a38673614ea!8m2!3d52.335665!4d4.8608044!16s%2Fg%2F11bw4g0psg?entry=ttu>


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://listserver.vu.nl/pipermail/jongkees-group.beta/attachments/20241008/c1e1596a/attachment-0001.html>